Shutterstock announced the immediate resignation of CEO Paul Hennessy on July 13, 2026, causing the company's stock to fall 2.83% to $8.25 per share. Following this, law firm Pomerantz LLP launched an investigation into whether Shutterstock and its executives engaged in securities fraud or other unlawful practices. Investors affected by this development are encouraged to contact the firm for potential class action participation. This situation highlights concerns about corporate governance and could impact Shutterstock's future operations and investor confidence.
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million, with an additional earnout of up to €50 million based on performance. This acquisition will expand IPG's Advanced Solutions portfolio in medical lasers, particularl...
Constellation Software Inc. announced it will hold a conference call and live webcast on August 12, 2026, at 8:00 a.m. ET to discuss its second quarter results. The company will release its quarterly earnings after the Toronto Stock Exchange closes o...
Kuehn Law, PLLC is investigating whether officers and directors of Rhythm Pharmaceuticals, Inc. breached their fiduciary duties through potential self-dealing. The investigation could lead to damages for shareholders and reforms in corporate governan...
